ARESTVYR Trademark

Trademark Overview

On Tuesday, March 13, 2012, a trademark application was filed for ARESTVYR with the United States Patent and Trademark Office. The USPTO has given the ARESTVYR trademark a serial number of 85568516. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, April 9, 2021. This trademark is owned by SIGA Technologies, Inc.. The ARESTVYR trademark is filed in the Pharmaceutical Products category with the following description:

Anti-viral pharmaceutical to prevent and/or treat orthopoxvirus-related diseases
arestvyr

General Information

Serial Number85568516
Word MarkARESTVYR
Filing DateTuesday, March 13, 2012
Status710 - CANCELLED - SECTION 8
Status DateFriday, April 9, 2021
Registration Number4597614
Registration DateTuesday, September 2, 2014
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, July 31, 2012

Trademark Statements

Goods and ServicesAnti-viral pharmaceutical to prevent and/or treat orthopoxvirus-related diseases

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, April 9, 2021
Primary Code005
First Use Anywhere DateTuesday, January 14, 2014
First Use In Commerce DateTuesday, January 14, 2014

Trademark Owner History

Party NameSIGA Technologies, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressNew York, NY 10065
Party NameSIGA Technologies, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNew York, NY 10065
Party NameSIGA Technologies, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCorvallis, OR 97333

Trademark Events

Event DateEvent Description
Friday, April 9, 2021CANCELLED SEC. 8 (6-YR)
Wednesday, March 18, 2020ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Monday, September 2, 2019COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Thursday, August 25, 2016ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, August 25, 2016TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, September 2, 2014REGISTERED-PRINCIPAL REGISTER
Tuesday, August 12, 2014NOTICE OF ACCEPTANCE OF STATEMENT OF USE MAILED
Friday, August 1, 2014NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Thursday, July 31, 2014ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Thursday, March 6, 2014STATEMENT OF USE PROCESSING COMPLETE
Wednesday, January 29, 2014USE AMENDMENT FILED
Wednesday, January 29, 2014TEAS STATEMENT OF USE RECEIVED
Wednesday, September 25, 2013NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, September 24, 2013EXTENSION 2 GRANTED
Friday, September 13, 2013EXTENSION 2 FILED
Friday, September 13, 2013TEAS EXTENSION RECEIVED
Wednesday, April 3, 2013APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, April 3, 2013TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, March 12, 2013NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, March 11, 2013EXTENSION 1 GRANTED
Wednesday, February 27, 2013EXTENSION 1 FILED
Monday, March 11, 2013CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, February 27, 2013TEAS EXTENSION RECEIVED
Tuesday, September 25, 2012NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, July 31, 2012OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, July 31, 2012PUBLISHED FOR OPPOSITION
Wednesday, July 11, 2012NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, June 20, 2012APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, June 20, 2012ASSIGNED TO EXAMINER
Thursday, March 22, 2012NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Friday, March 16, 2012NEW APPLICATION ENTERED IN TRAM

Related Keywords

arestvyr orthopoxvirus related diseases treat prevent viral pharmaceutical anti